Introduction
============

Human embryonic stem cells (hESCs) are pluripotent cells present in the inner cell mass of the blastocyst ([@ref-55]). They give rise *in vivo* to the three germ layers (ectoderm, endoderm and mesoderm) and therefore, have the ability to generate all tissues within the body. These cells can also be derived *in vitro* ([@ref-70]), maintaining an ability to either self-renew or differentiate ([@ref-33]). Human ESCs are a fundamental tool for understanding human embryonic development and constituent mechanisms of differentiation ([@ref-33]). Moreover, they represent a potentially powerful tool in drug screening ([@ref-30]) and regenerative medicine ([@ref-8]; [@ref-33]; [@ref-72]). However, in order to mobilise the potential of hESCs, it is necessary to understand the molecular determinants of self-renewal and differentiation.

The core transcriptional network regulating pluripotency ([@ref-9]; [@ref-12]; [@ref-14]; [@ref-45]; [@ref-57]) is composed of three transcription factors: octamer-binding protein 4 (OCT4) ([@ref-22]), sex determining region Y-box 2 (SOX2) ([@ref-20]) and NANOG ([@ref-27]; [@ref-79]). Interestingly, although these transcription factors clearly drive pluripotency ([@ref-39]; [@ref-69]), their expression is not restricted to hESCs ([@ref-5]; [@ref-35]; [@ref-40]; [@ref-56]; [@ref-80]). Thus, stemness must in part depend on other hESC specific characteristics, such as the context of expression of these three transcription factors. Protein--protein interaction networks may provide a valuable insight into this hESC specific context ([@ref-12]; [@ref-48]). Proteins of the cell microenvironment may also be an important part of this network ([@ref-18]; [@ref-66]; [@ref-67]), since this is the niche where cell--cell and cell-extracellular matrix (ECM) interactions occur, allowing selective cell communication. Indeed, it was through the addition of ECM proteins and growth factors that xeno-free culture conditions for hESCs were defined ([@ref-46]; [@ref-58]). These methods have facilitated investigation of the roles that extracellular molecules, such as heparan sulfate (HS) ([@ref-66]), fibroblast growth factor (FGF)-2 ([@ref-17]; [@ref-21]) and activin A ([@ref-74]) play in hESC self-renewal and differentiation. However, such factors have not always been linked to specific transcriptional networks and many of the defined medium formulations do not completely sustain pluripotency ([@ref-11]; [@ref-42]). Therefore, other factors involved in the maintenance of stemness must be missing. One key factor could be a wider link between ECM interactions and transcriptional networks, thereby establishing important relay mechanisms between endogenous and exogenous stemness regulators.

Data from large-scale transcriptomic and proteomic studies ([@ref-34]) facilitate the construction of large biological networks in which nodes and edges represent molecules and interactions respectively. Studying the topological properties of these networks may enable the elaboration of novel hypotheses. For instance, it has been shown that hubs, which are highly connected nodes within a network, are more likely to be important proteins in a protein--protein interaction network ([@ref-31]), as well as bottlenecks, which are nodes with a high betweenness centrality, meaning many shortest paths within the network pass through them ([@ref-78]).

To gain a more global insight into the potential contribution of the cell-microenvironment to stemness, we employed an *in silico* systems-level approach where a meta-analysis of dozens of microarrays was performed to establish a stringent yet more representative hESC transcriptome. Transcripts of transcriptional and extracellular proteins were used to build a putative interactome or protein--protein interaction network. The organisation of this network was then analysed to identify extracellular proteins with hub or bottleneck properties, which may be involved in determining stemness, as well as proteins connecting the extracellular factors to transcription.

Materials and Methods
=====================

Establishing hESC and hESC-derived transcriptomes
-------------------------------------------------

The microarray datasets used to establish a high coverage hESC transcriptome were raw data (.CEL image files) of single channel Human Genome U133 Plus 2.0 Affymetrix microarrays downloaded from the ArrayExpress public database ([@ref-52]). Probe intensity extraction and normalisation procedures were performed with BRB-ArrayTools 4.3.0 beta 1 ([@ref-64]) using default median array values (selected by BRB-ArrayTools 4.3.0 beta 1) as reference. The minimum required fold change was 1.5. If less than 20% of the expression values met this value, the gene was excluded. Each individual dataset was first analysed using the three available algorithms: Robust Multi-array Analysis (RMA) ([@ref-28]), GC-RMA ([@ref-73]) and Micro Array Suite 5.0 (MAS5.0) ([@ref-26]). The three lists of expressed genes were either combined to create a total list containing all expressed genes, or compared to create an intersection list containing only overlapping genes. For the hESC datasets, when the intersection list contained at least 50% of the genes of the total list, the dataset was used to perform a meta-analysis to establish the hESC transcriptome. Thus, all hESC datasets matching this criterion were grouped to be analysed together and generate the final intersection list used as the hESC transcriptome for further analysis ([Fig. 1](#fig-1){ref-type="fig"}). For the hESC-derived cell datasets, if the intersection list contained at least 50% of the genes of the total list, the full transcriptome (fibroblasts and endothelial cells) was used for transcriptomic comparisons; otherwise the datasets were combined to build the final intersection list and form the hESC-derived cell transcriptome, which was used for transcriptomic comparisons ([Fig. 1](#fig-1){ref-type="fig"}). The identifiers were EntrezGene IDs and Official Gene Symbol identifiers. The identifier conversion was done with the database for annotation, visualization and integrated discovery (DAVID) 6.7 ([@ref-24]; [@ref-25]).

![Flow chart of the microarray dataset analysis.\
This flow chart describes the microarray meta-analysis process ending by the transcriptome establishment of hESC, endothelial cells, fibroblasts and mixed hESC-derived cells.](peerj-02-618-g001){#fig-1}

Selection of extracellular and transcription related sub-transcriptomes
-----------------------------------------------------------------------

The extracellular (EC) and the transcription factor related (TF) components of the transcriptomes were extracted using the Gene Ontology (GO) database ([@ref-3]). The terms used were: [GO:0005576](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0005576) (extracellular region) and [GO:0009986](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0009986) (cell surface) for the EC component; [GO:0005667](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0005667) (transcription factor complex), [GO:0008134](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0008134) (transcription factor binding), [GO:0000988](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0000988) (protein binding transcription factor activity) and [GO:0001071](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0001071) (nucleic acid binding transcription factor activity) for the TF component. Genes involved in biological processes (e.g., cell cycle ([GO:0007049](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0007049)), cell adhesion ([GO:0007155](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0007155)), cell communication ([GO:0007154](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0007154)), cell junction ([GO:0030054](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0030054)) and cytoskeleton organization ([GO:0007010](http://amigo.geneontology.org/amigo/search/ontology?q=GO:0007010))) were also highlighted.

By using a published list of HS binding proteins ([@ref-50]), the EC component was divided into two distinct groups: genes coding for HS binding proteins and those coding for non-HS binding proteins.

The hESC transcriptome was compared with the three different hESC-derived cell transcriptomes to establish which mRNAs were only expressed in hESC (the specific part) and which ones were expressed in all analysed transcriptomes (the common part).

Construction and analysis of putative interactomes
--------------------------------------------------

Putative interactomes were built with the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) 9.0 database ([@ref-68]) using interaction data from experimental/biochemical experiments and association in curated databases only, which excludes interaction predictions by neighbourhood in the genome, gene fusions, co-occurrence across genomes, co-expression and text-mining (co-mentioned in PubMed abstracts). A stringent interaction confidence of 0.7 was imposed to ensure a higher probability that the predicted links exist ([@ref-68]).

### Analysis of network structure

Cytoscape 2.8.0 software ([@ref-63]) and associated plug-ins were used to visualise and analyse protein--protein interaction networks. Randomised networks were created by the RandomNetworks v1.0 plug-in from the real protein--protein interaction networks. Therefore, each random network had the same number of nodes *N* and edges *L* as its corresponding real network. Network topological parameters, such as connected components, average degree 〈*k*〉, degree distribution *P*(*k*), average clustering coefficient 〈*C*〉, clustering coefficient distribution *C*(*k*) and characteristic path length 〈*l*〉, were computed with the NetworkAnalyser plug-in. Statistical analysis was performed using IBM SPSS Statistics 21 software.

### Enrichments analysis of interactome components

Kyoto Encyclopedia of Genes and Genomes (KEGG) ([@ref-32]) pathway and GO Biological Processes term enrichments were processed using DAVID 6.7 ([@ref-24]; [@ref-25]) for the analysis of transcriptome subsets. Terms were recorded when the EASE score was ⩽ 0.1 and considered significantly enriched when the false discovery rate was ⩽ 0.05. Enrichment was calculated through two different ways: the ratio of the ratio of proteins belonging to the term in the analysed list and the ratio of proteins belonging to the term in *Homo sapiens*, or hESCs.

Selection of candidate proteins
-------------------------------

Proteins with a degree *k* in the top 20% were considered as hubs, while proteins with a betweenness in the top 20% were considered as bottlenecks ([@ref-78]). The EC/TF and specific/common interfaces were established from the hESC sub-interactome, constructed with STRING data (edge confidence of 0.7) and containing EC and TF components only. To be part of the EC/TF interface network, an EC node had to be connected to at least one TF node and *vice-versa*. Similarly, to be part of the specific/common interface, a specific node had to be connected to a least one common node and *vice-versa*. In this complete (ALL_EC+TF) list of candidate proteins composed of the two interfaces, hubs and bottlenecks, only the EC nodes from the specific and common parts were kept to establish the final (C+S_EC) short list of candidate proteins ([Fig. 2](#fig-2){ref-type="fig"}). The KEGG pathway and GO Biological Processes term enrichments were processed as previously. Statistical analysis was performed using IBM SPSS Statistics 21 software and presented as mean ± SEM.

![Establishment of the list of candidates, a flow chart.\
This flow chart describes the candidate choice process from the hESC transcriptome to the final list of 92 proteins.](peerj-02-618-g002){#fig-2}

Results
=======

The hESC transcriptome
----------------------

To discover new regulators of hESC pluripotency, 24 hESC microarrays were analysed from four different datasets ([Table 1](#table-1){ref-type="table"}). A total of 8,934 genes were found to be expressed, which constitute the high coverage hESC transcriptome ([Table S1](#supp-2){ref-type="supplementary-material"}). To establish hESC specific expression profiles, three different early hESC-derived cell transcriptomes were extracted from analogous fibroblast (5,086 mRNAs), endothelial cells (5,522 mRNAs) or mixed hESC-derived cells (10,730 mRNAs, [Table 1](#table-1){ref-type="table"} and [Table S1](#supp-2){ref-type="supplementary-material"}).

10.7717/peerj.618/table-1

###### Microarray datasets analysis.

The access number (second column) gives access to the dataset in ArrayExpress database. Cell types and cell lines (first column), main cell culture conditions (third column), publications linked to the dataset (when available, fourth column) and the number of microarrays used per analysis (fifth column) are specified. Expressed gene lists for each algorithm (RMA, GC-RMA and MAS5.0) as the total and intersection lists are presented. Four hESC datasets ([E-GEOD-6561](E-GEOD-6561), [-15148](-15148), [-18265](-18265) and [-26672](-26672)) have been used to build mix1. Six hESC-derived cell datasets ([E-GEOD-9196](E-GEOD-9196), [-9832](-9832), [-9940](-9940), [-14897](-14897), [-19735](-19735) and [-21668](-21668)) have been used to build mix2. Datasets in bold represent the final transcriptomes used for further analysis: mix1 for hESCs, [E-GEOD-9832](E-GEOD-9832) for the fibroblasts, [E-GEOD-19735](E-GEOD-19735) for the endothelial cells and mix2 for the mixture of hESC-derived cells.

![](peerj-02-618-g007)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cell type (Cell line)      Access number                      Linked publication   Main cell culture feature                                                                                          Number of microarrays   RMA          GC-RMA       MAS5.0       Total        Intersection
  -------------------------- ---------------------------------- -------------------- ------------------------------------------------------------------------------------------------------------------ ----------------------- ------------ ------------ ------------ ------------ --------------
  hESCs (H14)                [E-GEOD-6561](E-GEOD-6561)         ([@ref-10])          On feeder cells (irradiated MEFs) FGF2 (4 ng/mL) 20% KnockOut SR                                                   4                       9,672        8,680        9,822        11,930       7,088

  hESCs (H1, H7,\            [E-GEOD-15148](E-GEOD-15148)       ([@ref-77])          On feeder cells (irradiated MEFs) FGF2 (100 ng/mL) 20% KnockOut SR OR On feeder-free matrigel Conditioned medium   10                      8,798        10,554       10,293       12,467       7,395
  H9, H13, H14)                                                                                                                                                                                                                                                                     

  hESCs                      [E-GEOD-18265](E-GEOD-18265)       /                    On feeder cells (inactivated HFFs) FGF2 (10 ng/mL) 20% KnockOut SR                                                 5                       9,602        11,325       10,966       13,499       7,791

  hESCs (H1)                 [E-GEOD-26672](E-GEOD-26672)       ([@ref-23])          On feeder cells (irradiated MEFs) FGF2 (4 ng/mL) 20% KnockOut SR                                                   5                       9,656        11,285       10,843       12,790       8,235

  **hESCs**                  **Mix1**                           **/**                                                                                                                                   **24**                  **11,001**   **12,173**   **11,546**   **14,043**   **8,934**

  Embryoid bodies            [E-GEOD-9196](E-GEOD-9196)         ([@ref-41])                                                                                                                             9                       5,142        6,308        6,667        8,935        3,576

  Blast cells                                                   9                    4,142                                                                                                              5,866                   6,731        8,617        3,175                     

  **Fibroblasts**            **[E-GEOD-9832](E-GEOD-9832)**     **([@ref-51])**                                                                                                                         **3**                   **6,471**    **7,510**    **8,072**    **9,795**    **5,086**

  Neural progenitors         [E-GEOD-9940](E-GEOD-9940)         /                                                                                                                                       12                      6,939        8,432        7,309        11,517       3,944

  Embryoid bodies                                               3                    1,356                                                                                                              2,485                   5,009        5,812        942                       

  Hepatic cells              [E-GEOD-14897](E-GEOD-14897)       ([@ref-65])                                                                                                                             3                       1,669        2,659        4,017        4,864        1,299

  **Endothelial cells**      **[E-GEOD-19735](E-GEOD-19735)**   **/**                                                                                                                                   **4**                   **7,166**    **9,237**    **8,448**    **11,085**   **5,522**

  Embryoid bodies                                               2                    704                                                                                                                1,832                   1,156        2,079        583                       

  Mesenchemal progenitors    [E-GEOD-21668](E-GEOD-21668)       ([@ref-19])                                                                                                                             3                       861          1,482        2,543        3,087        638

  **Differentiated cells**   **Mix2**                           **/**                                                                                                                                   **48**                  **16,174**   **14,172**   **12,134**   **17,458**   **10,730**
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes.**

MEFsmouse embryonic fibroblastsHFFshuman foreskin fibroblastsSRserum replacer

The mRNAs specifically expressed by the hESCs (1,010 mRNAs) and those common to hESCs and hESC-derived cells (1,933 mRNAs) were identified by comparing the hESC trancriptome with the hESC-derived trancriptomes ([Fig. 3A](#fig-3){ref-type="fig"}). Gene Ontology (GO) annotation database ([@ref-3]) was then used to identify the hESC transcription factor (TF) related (721 mRNAs) and extracellular (EC) transcripts. In this last set of mRNAs, a distinction between transcripts coding for HS binding proteins (191 mRNAs) and non-binding proteins (576 mRNAs, [Fig. 3B](#fig-3){ref-type="fig"} and [Table S1](#supp-2){ref-type="supplementary-material"}) was enabled by a published list of HS binding proteins ([@ref-50]).

![Overlaps of transcriptomes and sub-transcriptomes.\
(A) Main overlaps of hESC and hESC-derived cell transcriptomes. Grey, hESC transcriptome; Blue, endothelial cell transcriptome; Red: fibroblast transcriptome; Green: mixture of hESC-derived cell transcriptome. (B) The overlaps of hESC sub-transcriptomes. The hESC transcriptome is composed of 8,934 mRNAs in total with a hESC-specific part (1,010 mRNAs, brown part), a common part (1,933 mRNAs, blue part) shared with the hESC-derived cells, and the rest of the mRNAs (grey). Sub-transcriptomes can be highlighted: the HS binding proteins part (191 mRNAs, specific in red and common in pink); the extracellular part (EC) without HS binding proteins (576 mRNAs, specific in orange and common in purple); the transcription factor related part (TF, 721 mRNAs, specific in yellow and common in light blue).](peerj-02-618-g003){#fig-3}

Transcriptome analysis showed that genes known to be involved in stemness were represented in this hESC transcriptome, such as POU class 5 homeobox 1 (POU5F1, which encodes OCT4 protein) ([@ref-49]) and SOX2 ([@ref-6]). As expected, some of these were in the hESC specific subset, such as the telomerase reverse transcriptase (TERT) ([@ref-76]) and growth differentiation factor 3 (GDF3) ([@ref-36]) ([Table 2A](#table-2){ref-type="table"}). Interestingly, NANOG ([@ref-13]) was not present here. Some germ layer markers were also found in the hESC transcriptome, but they were never specific ([Table 2B](#table-2){ref-type="table"}). Lastly, many common additions to cell culture medium, which have been observed to facilitate hESC growth *in vitro*, such as FGF2 ([@ref-17]; [@ref-71]) and activin A ([@ref-74]) were also present ([Table 2C](#table-2){ref-type="table"}).

10.7717/peerj.618/table-2

###### Transcriptomes and literature comparisons, a selection of markers.

'Transcriptome' column: transcriptome(s) or sub-transcriptome containing the mRNAs. (A) Signalling molecules required for pluripotency/self-renewal; (B) Germ layer markers and (C) Molecules related to culture medium of hESCs.

![](peerj-02-618-g008)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                 Marker/Family                                                 Acronym                              Name                               Transcriptome      GO term
  ------------------------------ ------------------------------------------------------------- ------------------------------------ ---------------------------------- ------------------ --------------
  **A**                          **Embryonic stem cell**                                       PTEN                                 phosphatase and tensin homolog     hESC (COMMON)      CS/CA/CC/Cco

  TERT                           telomerase reverse transcriptase                              hESC (SPECIFIC)                                                                            

  GDF3                           growth differentiation factor 3                               hESC (SPECIFIC)                      EC non-HS                                             

  NODAL                          nodal homolog (mouse)                                         hESC (SPECIFIC)                      CCo/EC non-HS                                         

  ZIC3                           Zic family member 3                                           hESC, Mix                            TF                                                    

  SOX2                           SRY (sex determining region Y)-box 2                          hESC, Mix                            CC/CCo/TF                                             

  POU5F1                         POU class 5 homeobox 1                                        hESC, Mix                            CCo/TF                                                

  **B**                          **Ectoderm**                                                  NEFH                                 neurofilament, heavy polypeptide   hESC (COMMON)      CS

  TUBB3                          tubulin, beta 3 class III                                     hESC, Mix                            CCo                                                   

  **Endoderm**                   KRT19                                                         keratin 19                           hESC (COMMON)                      CS                 

  SOX7                           SRY (sex determining region Y)-box 7                          hESC, Endo, Mix                      CCo/TF                                                

  **Mesoderm**                   KDR                                                           kinase insert domain receptor\       hESC, Mix                          CA/CCo/HS          
                                                                                               (a type III receptor tyrosine\                                                             
                                                                                               kinase) (VEGFR)                                                                            

  PDGFRA                         platelet-derived growth factor\                               hESC (COMMON)                        CS/CA/CCo                                             
                                 receptor, alpha polypeptide                                                                                                                              

  VIM                            vimentin                                                      hESC (COMMON)                        CS                                                    

  **C**                          **Fibronectin**                                               FN1                                  fibronectin 1                      hESC (COMMON)      CA/HS

  ITGA5                          integrin, alpha 5 (fibronectin receptor, alpha polypeptide)   hESC, Mix                            CA/CCo/J/HS                                           

  ITGB1                          integrin, beta 1 (fibronectin\                                hESC, Endo, Mix                      CS/CA/CC/CCo/J/HS                                     
                                 receptor, beta\                                                                                                                                          
                                 polypeptide, antigen CD29\                                                                                                                               
                                 includes MDF2, MSK12)                                                                                                                                    

  **Fibroblast growth factor**   FGF2                                                          fibroblast growth factor 2           hESC (COMMON)                      CC/CCo/HS/TF       

  FGFR1                          fibroblast growth factor receptor 1                           hESC (COMMON)                        CC/CCo/HS                                             

  FGFR2                          fibroblast growth factor receptor 2                           hESC, Endo, Mix                      CC/CCo/HS                                             

  FGFR3                          fibroblast growth factor receptor 3                           hESC, Endo, Mix                      CCo/J/HS                                              

  FGFR4                          fibroblast growth factor receptor 4                           hESC (SPECIFIC)                      CCo/J/HS                                              

  **Activin A**                  ACVR1B                                                        activin A receptor, type IB (ALK4)   hESC (COMMON)                      CC/CCo/EC non-HS   

  ACVR1C                         activin A receptor, type IC                                   hESC (SPECIFIC)                      CCo                                                   

  ACVR2A                         activin A receptor, type IIA                                  hESC, F, Mix                         CCo                                                   

  ACVR2B                         activin A receptor, type IIB                                  hESC, Endo, Mix                      CCo/EC non-HS                                         

  INHBA                          inhibin, beta A/Activin A                                     hESC (COMMON)                        CC/CCo/HS                                             
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes.**

Endoendothelial cellFfibroblastMixmixture of hESC-derived cellsGO term columnGO terms found during the GO extractionCAcell adhesionCCcell cycleCCocell communicationCScytoskeleton organisationJcell junctionECextracellular partHSheparan sulfate binding proteinsTFtranscription factor related part

Putative extracellular/transcriptional interactomes
---------------------------------------------------

As the aim of this study was to learn more about the potential importance of functional links between cell/cell--matrix interactions and transcription, putative protein--protein interaction networks containing only transcriptional and extracellular components (EC+TF) were established by means of the STRING database ([@ref-68]) using transcriptional expression data as a proxy for protein expression profiles. Two interactomes were built: one (called ALL) containing all identified EC+TF proteins, composed of 702 nodes and 3,201 edges ([Data S1A](#supp-1){ref-type="supplementary-material"}), and one (called C+S) containing only those transcripts/proteins that were either specific to hESCs or common to hESCs and hESC-derived cells, comprising 209 nodes and 371 edges ([Data S1B](#supp-1){ref-type="supplementary-material"}).

The average clustering coefficient 〈*C*〉 (indicating the network cohesiveness) was closer to zero for all randomised networks compared to both ALL and C+S interactomes, implying a significantly higher occurrence of clusters in these selected networks ([Fig. 4A](#fig-4){ref-type="fig"}).

![General network parameters of EC+TF putative interactomes.\
(A) The average clustering coefficient of real networks and their corresponding average randomised networks with SEM bars (One sample *t*-test, *n* = 5, *p*-value \<0.001). (B) The node degree distribution *P*(*k*) and (C) the clustering coefficient distribution *C*(*k*). C, common part; S, specific part; R, random; EC, extracellular part; TF, transcription factor related part.](peerj-02-618-g004){#fig-4}

As observed in previous protein--protein interaction network studies ([@ref-1]; [@ref-31]), both selected networks (ALL and C+S) and randomised networks exhibit a scale free structure, where the degree distribution *P*(*k*) follows a power-law *P*(*k*) ∼ *k*^−*γ*^, involving the presence of hubs ([Fig. 4B](#fig-4){ref-type="fig"} and [Table S2](#supp-3){ref-type="supplementary-material"}), and the clustering coefficient distribution *C*(*k*) is independent of *k* meaning there is no inherent presence of modules unlike hierarchical networks, even if there was a tendency of the real networks to be hierarchical (*C*(*k*) ∼ *k*^−*β*^) compared to the randomised versions ([Fig. 4C](#fig-4){ref-type="fig"}).

These results demonstrate that the EC+TF putative protein--protein interaction networks were suitable for further analysis.

Enrichment analysis
-------------------

GO Biological Processes term and KEGG pathway enrichments were used to determine if the EC+TF putative interactomes contained significantly enriched subsets of proteins. As expected, terms related to EC (*extracellular matrix organization*), and TF (*transcription, DNA templated*) appeared. More interestingly, terms relating to development (*embryonic development*) and pathways already known to be involved in hESC stemness maintenance (transforming growth factor (TGF)- *β* ([@ref-29]) or wingless-type MMTV integration site family (Wnt) ([@ref-60])) and differentiation (bone morphogenic protein (BMP) signalling ([@ref-75])) were also identified. KEGG *Pathways in cancer* as well as GO terms of cell differentiation, cell adhesion, cell communication and cell proliferation were represented too ([Fig. 5](#fig-5){ref-type="fig"} and [Table S3A](#supp-4){ref-type="supplementary-material"}).

![GO/KEGG analyses of EC+TF putative interactomes.\
(A) GO Biological Processes term enrichment (against *Homo sapiens*), in fold change. (B) Percentage of the total number of proteins in *Homo sapiens* related to GO Biological Processes that are present in ALL and C+S putative interactomes. C, common part; S, specific part.](peerj-02-618-g005){#fig-5}

Fewer terms were found to be significantly enriched when only the common and specific parts (from ALL to C+S) were analysed. However, when they were found significant, the vast majority was more enriched, except the terms related to TF ([Table S3A](#supp-4){ref-type="supplementary-material"}). *Nuclear-transcribed mRNA catabolic process* (representing 56% of ALL and 48% of C+S) and *multicellular organismal development* (representing 47% of ALL and 54% of C+S) were the most represented non-related terms ([Table S3A](#supp-4){ref-type="supplementary-material"}).

Interestingly, *regulation of cellular component movement* was well enriched with fold changes in ALL of 5.8 (*Homo sapiens* as background)/4.6 (hESC as background) and in C+S of 9.4 (*Homo sapiens* as background)/7.4 (hESC as background). 28%/51% of the proteins belonging to this term in *Homo sapiens*/hESC were represented in ALL and 17%/31% in C+S ([Tables S3A](#supp-4){ref-type="supplementary-material"}).

These data show that the EC+TF putative interactomes, both ALL and C+S, still contained the subsets of proteins involved in development, cell differentiation, cell adhesion and cell communication.

Novel proteins potentially associated with stemness
---------------------------------------------------

The final list of potential stemness proteins was established from ALL, the EC+TF putative protein--protein interaction network. This list (called ALL_EC+TF) was composed of nodes with hub or bottleneck features, as well as nodes within the specific/common and EC/TF interfaces ([Fig. 2](#fig-2){ref-type="fig"}). Hubs are thought to be functionally important due to their high number of interactions, while bottlenecks form links between different processes. 58% of the bottlenecks in the ALL network were also hubs. The specific/common interface reflects the links between the more general cell functions and those specific to hESCs. The EC/TF interface represents points of communication between the genome and the cell's environment, including other cells. The ALL_EC+TF contained 387 candidates (49% EC and 55% TF) with 29 specific (8%) and 126 common (33%) nodes. The key transcription factors OCT4 and SOX2 were present as hubs and part of the EC/TF interface ([Table S4A](#supp-5){ref-type="supplementary-material"}).

Considering GO set (TF, EC) enrichment with regards to proteins belonging to common or specific parts of the transcriptome, the specific subset was enriched in non-HS binding EC proteins (1.7-fold change), whereas the common subset was enriched in HS binding proteins (1.6-fold change) ([Fig. 6A](#fig-6){ref-type="fig"}). In addition the common subset was found to be enriched in both hubs (1.3-fold change) and bottlenecks (1.6-fold change) ([Fig. 6B](#fig-6){ref-type="fig"}). Finally, hubs were enriched in TF (1.4-fold change) and bottlenecks in HS binding proteins (1.3-fold change, [Fig. 6B](#fig-6){ref-type="fig"}).

![Comparative enrichment trends within the candidate protein list.\
(A) Enrichments in specific, common and other parts with HS, EC non-HS and TF. (B) Enrichments in HS, EC non-HS and TF parts with EC/TF interface, C/S interface, hubs and bottlenecks. C, common part; S, specific part; EC, extracellular part; HS, heparan sulfate binding proteins; TF, transcription factor related part.](peerj-02-618-g006){#fig-6}

To assess the validity of the candidate prediction, a random ALL_EC+TF list was established the same way using a randomised version of the EC+TF putative interactome ([Tables S4B](#supp-5){ref-type="supplementary-material"}). The hub subset was identical in both real and random versions of the candidate list due to the way the randomised network was generated. However, the bottleneck subset in the real list had proteins with significantly higher betweenness centrality (7,456 ± 835, paired sample test, *n* = 134, *p*-value \<0.001) than the one in the random list (0.0108 ± 0.0005). Moreover, the random list with 581 proteins retained 83% of the original EC+TF putative interactome against 55% for the real list. The comparison between the real list of candidates and its random version showed that the filtering process was meaningful.

Three shortened lists were generated from ALL_EC+TF list to decrease the number of candidates by either keeping only EC proteins (ALL_EC, 188 proteins, [Table S4C](#supp-5){ref-type="supplementary-material"}) or/and C+S proteins (C+S_EC+TF, 155 proteins, [Table S4D](#supp-5){ref-type="supplementary-material"} and C+S_EC, 92 proteins, [Table S4E](#supp-5){ref-type="supplementary-material"}) as described in [Fig. 2](#fig-2){ref-type="fig"}. 59% of the common proteins in the longest ALL_EC+TF list and 62% of the specific ones were conserved in the shortest C+S_EC list. Similarly, 9% of the hubs and 20% of the bottlenecks were kept.

To determine if each list and each subset (hubs, bottlenecks and interfaces, as well as specific, common and other proteins from the complete (ALL_EC+TF) to the shortest (C+S_EC) list) still contained proteins potentially involved in stemness maintenance, we undertook further GO Biological Processes term and KEGG pathway enrichments ([Table S3B--I](#supp-4){ref-type="supplementary-material"}). Only the subset containing the hESC-specific proteins was found without any significant enrichment regarding the analysed terms and pathways ([Table S3C](#supp-4){ref-type="supplementary-material"}). However, the most represented term in both specific subsets from the ALL_EC+TF and ALL_EC, as well as in the four full lists and in all other subsets, was *multicellular organismal development* ([Table S3B--I](#supp-4){ref-type="supplementary-material"}).

Again, terms and pathways related to TF appeared in ALL_EC+TF and C+S_EC+TF lists, as well as in all the other subsets of these two lists ([Table S3B,D--I](#supp-4){ref-type="supplementary-material"}). These TF terms and pathways were logically lost in the ALL_EC and C+S_EC lists and subsets.

GO terms related to cell differentiation, cell adhesion, cell communication, cell movement or cell proliferation, and KEGG *pathways of cancer* were still significantly enriched in the four lists and in the vast majority of the analysed subsets ([Table S3B,D--I](#supp-4){ref-type="supplementary-material"}).

These data demonstrate that the four lists of candidates, as well as each subset of proteins (hubs, bottlenecks, specific/common and EC/TF interfaces) incorporated proteins involved in development and cell communication. Focusing on the EC proteins that were either specific to hESCs or common to hESCs and hESC-derived cells allowed us to reduce the number of candidates to 92 proteins ([Table 3](#table-3){ref-type="table"} and [Table S4E](#supp-5){ref-type="supplementary-material"}), while insuring that proteins potentially involved in stemness maintenance were retained. Among these proteins, some are already known to be required for maintenance of hESC stemness, either directly, such as NODAL ([@ref-29]; [@ref-71]), FGF2 ([@ref-17]; [@ref-71]) and activin A ([@ref-74]), or indirectly through signalling pathways such as TGF-*β* ([@ref-29]) or Wnt ([@ref-60]). Other proteins are also known to play a role in mouse ESC pluripotency, but not yet in hESC, such as the transcription factor 3 (TCF3) ([@ref-15]). However, for the majority of candidates, including titin, nothing is known yet about their functions in the context of hESCs.
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###### The list of candidates, an overview.

The 'hubs' column gives the degree; the 'bottlenecks' column gives the betweenness; the 'S/C' column indicates if the protein is in the specific/common interface; the 'EC/TF' column indicates if the protein is in the EC/TF interface; the 'KEGG pathway' column indicates the number of pathway involving each protein (see [Table S4](#supp-5){ref-type="supplementary-material"} for a complete list).
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             Acronym                                         Name                 GO term        Hubs      Bottlenecks   S/C   EC/TF   KEGG pathway
  ---------- ----------------------------------------------- -------------------- -------------- --------- ------------- ----- ------- --------------
  **C**      ACTN4                                           actinin, alpha 4     EC non-HS/CS   17                                    4
  ACVR1B     activin A receptor, type IB (ALK4)              EC non-HS/CC/CCo                              X             X     1       
  ADM        adrenomedullin                                  EC non-HS/CCo                       4050.8    X             X     0       
  BMP2       bone morphogenetic protein 2                    HS/CC/CCo                           2693.9    X             X     3       
  DMD        dystrophin                                      EC non-HS/CS/CCo                              X                   0       
  FGFR1      fibroblast growth factor receptor 1             HS/CC/CCo                           2634.2    X             X     5       
  FN1        fibronectin 1                                   HS/CA                26             6988.8                  X     5       
  IL6        Interleukin 6                                   HS/CCo                                                      X     4       
  INHBA      inhibin, beta A/Activin A                       HS/CC/CCo                                     X                   2       
  ITGA6      integrin, alpha 6 (CD49f)                       EC non-HS/CA/CCo/J   40             15218.1                 X     6       
  ITGAV      integrin, alpha V (vitronectin receptor)        HS/CA/CCo            40             12409.4                 X     6       
  JAM3       junctional adhesion molecule 3                  EC non-HS/CA/CCo/J                            X             X     2       
  LAMA1      laminin, alpha 1                                HS/CA/CCo            15                                     X     4       
  MET        hepatocyte growth factor receptor               HS/CS/CC/CCo         24             10501.7   X             X     6       
  PLAT       plasminogen activator, tissue                   HS/CCo                              2552.8                  X     0       
  PLAU       plasminogen activator, urokinase                HS/CA/CCo                                                   X     1       
  SERPINE1   serpin peptidase inhibitor, clade E, member 1   HS/CA/CCo            24             10022.8                 X     1       
  SERPINI1   serpin peptidase inhibitor, clade I, member 1   EC non-HS/CA                                                X     0       
  TGFB2      transforming growth factor, beta 2              HS/CA/CC/CCo         25             10580.8   X             X     6       
  THBS1      thrombospondin 1                                HS/CA/CC/CCo                        2066.0                  X     5       
  VEGFA      vascular endothelial growth factor A            HS/CA/CCo            16             6817.1                  X     6       
  **S**      CDH8                                            cadherin 8, type 2   HS/CA                                  X     X       0
  FGF4       fibroblast growth factor 4                      HS/CA/CCo                                     X             X     3       
  FGFR4      fibroblast growth factor receptor 4             HS/CCo                                        X             X     4       
  IDE        insulin-degrading enzyme                        EC non-HS/CCo                                 X                   0       
  INHBE      inhibin, beta E                                 EC non-HS                                     X                   2       
  NODAL      nodal homolog (mouse)                           EC non-HS/CCo                                 X                   1       
  PLXNB1     plexin B1                                       EC non-HS/CCo                                 X                   0       
  TTN        titin                                           EC non-HS/CS/CC                               X             X     0       
  WIF1       WNT inhibitory factor 1                         EC non-HS/CCo                                 X             X     1       

**Notes.**

GOGene OnlotogyKEGGKyoto Encyclopedia of Genes and GenomesCcommon partSspecific partECextracellular partTFtranscription factor related partJcell junction

Discussion
==========

We provide a novel picture of the hESC transcriptome built from a meta-analysis and allowing the *in silico* analysis of a putative hESC protein--protein interaction network. This systems-level approach has been used to identify proteins potentially involved in the maintenance of stemness.

Transcriptomic data provide the most comprehensive insight into variations in cell type or condition specific gene expression profiles. Therefore, data from multiple microarray studies were chosen to generate putative interactomes due to the lack of corresponding comprehensive proteomic profiles. Even if mRNA and protein levels have been suggested to correlate weakly, this correlation may be stronger than anticipated, though this depends on the techniques used to measure mRNA ([@ref-37]; [@ref-53]; [@ref-61]; [@ref-62]). Thus, the present study provides a predictive qualitative insight into sub-networks of proteins, which may mediate or maintain human stem cell pluripotency.

The decision to selectively include genes only found by three different algorithms allowed a reduction in the number of false positives in the whole transcriptome, but probably amplified the number of false negatives, which may explain the absence of NANOG. Regarding the specific/common distinction, this pipeline permitted confidence about the common mRNA subset, whereas it likely increased the false positive rate in the specific mRNA subset, which is still half of the common one. However, the use of transcriptomic data from different hESC lines cultured under different conditions highlighted the core transcriptome of these cells.

Not all mRNAs were represented in the putative protein--protein interaction network, probably because coverage of human protein--protein interactions in all databases, including STRING, remains incomplete ([@ref-16]). High edge stringency limits imposed in this study should minimise inclusion of false positive interactions ([@ref-16]), thereby increasing confidence in the relevance and utility of predicted networks.

The scale-free nature of the EC+TF putative interactomes mean that they should exhibit a high error tolerance thanks to redundancy and a high attack vulnerability, due to the presence of hubs ([@ref-1]).

Even incomplete interactomes are very complex structures. In order to focus on the likely most important proteins within this interactome, four selection criteria were applied, the first being the selection of hESC hubs. These proteins constitute a small, but often essential part of the interactome ([@ref-7]). For example, deletion of just one hub in yeast is often lethal ([@ref-31]). The second was the selection of bottlenecks, which link processes and so permit cross-talk. The third and the fourth criteria involved were that proteins had to be in the specific/common or EC/TF interfaces. These interfaces are posited to be important, as they reflect communication links between the nucleus and the extracellular matrix, and between the specific and common proteins, which ultimately make hESCs different from other cell types.

Interestingly, the GO term related to cell motility regulation was strongly represented in the candidate lists. Cell movement is a key component of morphogenesis. It is usually accomplished by three steps (protrusion, adhesion and de-adhesion) where cytoskeleton and ECM are involved ([@ref-2]). This may be significant as recent data indicate that cell motion may be an intrinsic feature of hESCs ([@ref-38]).

*Regulation of cell proliferation* also appeared in our analysis of candidate lists. This may be significant, as cell proliferation is a key property of hESCs, since these cells are able to proliferate almost indefinitely *in vitro* ([@ref-47]). This capability is sustained by the EC part with growth factors (Activin A ([@ref-11]) and FGF2 ([@ref-75])) and ECM molecules (fibronectin ([@ref-11]) or laminin ([@ref-58])), as well as by the TF part through the Smad signalling pathway ([@ref-29]; [@ref-71]). Cell proliferation can also be linked to the significant enrichment of cancer pathways in hESCs. Several links arise between cancer and hESCs, for example, the formation of teratomas as a test to assess pluripotency.

Conclusion
==========

Mechanisms involved in stemness are complex, multi-level and determined by the intrinsic cell potential, cell/cell and cell/matrix interactions. The meta-analysis of transcriptomic data in this study has allowed the construction of a hESC putative protein--protein interaction network from which novel ECM proteins have been identified as potential stemness regulators.

Networks are a snapshot of a dynamic model ([@ref-4]; [@ref-54]). Notions of attractors (or cell stable stationary states), landscapes formed with valleys (attractors) and hills (barriers between attractors), and cell state transitions described by dynamic systems theory will complete this systems biology approach and bring new hypotheses on hESC behaviour ([@ref-43]; [@ref-44]; [@ref-54]; [@ref-59]).
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###### The hESC putative interactomes

The hESC EC+TF putative interactomes (A) ALL and (B) C+S (C, common part; S, specific part). (Cytoscape file)

###### 

Click here for additional data file.
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###### List of mRNAs forming hESC and hESC-derived transcriptomes

Each mRNA is identified by the EntrezGene ID, the Official Gene Symbol and the full gene name. 'Transcriptome' column: transcriptome(s) or sub-transcriptome containing the mRNAs (hESC: human embryonic stem cells; Endo, endothelial cell; F, fibroblast; Mix, mixture of hESC-derived cells). Colour code (see Legend sheet) indicates different transcriptome and sub-transcriptomes. GO term column, GO terms found during the GO extraction (CA, cell adhesion; CC, cell cycle; CCo, cell communication; CS, cytoskeleton organisation; J, cell junction; EC, extracellular part; HS, heparan sulfate binding proteins; TF, transcription factor related part). (Excel file)

###### 

Click here for additional data file.
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###### General network parameters

ALL R is the randomised network from the ALL interactome while C+S R is the randomised network from the C+S interactome (C: common part; S: specific part; R: random). Power law of the degree distribution: with *R*^2^, the polynomial regression coefficient (degree 2).

###### 

Click here for additional data file.
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###### GO/KEGG analyses

GO Biological Processes term and KEGG pathway enrichments analysis of (A) EC+TF interactomes, (B) full lists of candidates and (C--I) subsets of candidates (EC, extracellular part; TF, transcription factor related part).

###### 

Click here for additional data file.
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###### The complete list of candidates

Each protein is identified by its corresponding EntrezGene ID, gene acronym and full gene name. 'Transcriptome' column: transcriptome(s) or sub-transcriptome containing the corresponding mRNA (Endo: endothelial cell; F, fibroblast; Mix, mixture of hESC-derived cells). A colour code is applied to aid recognition of each transcriptome and sub-transcriptome (see the Legend sheet). GO term column: GO terms found during the GO term analysis (CA, cell adhesion; CC, cell cycle; CCo, cell communication; CS, cytoskeleton; J, cell junction; EC, extracellular part; HS, heparan sulfate binding proteins; TF, transcription factor related part). "Hubs" column: indicates the number of edges associated with each hub protein. 'S/C' and 'EC/TF' columns: indicates if a protein is in the specific/common interface or extracellular/transcription factor interface respectively. (A) the longest ALL_EC+TF list of candidates, (B) the random list, (C) the ALL_EC list, (D) the C+S_EC+TF list and (E) the shortest C+S_EC list of candidate proteins, in which C, common part and S, specific part. (Excel file)

###### 

Click here for additional data file.

Analyses were performed using BRB-ArrayTools developed by Dr Richard Simon and BRB-ArrayTools Development Team.
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